<?xml version="1.0" encoding="UTF-8"?><!DOCTYPE article  PUBLIC "-//NLM//DTD Journal Publishing DTD v3.0 20080202//EN" "http://dtd.nlm.nih.gov/publishing/3.0/journalpublishing3.dtd"><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" dtd-version="3.0" xml:lang="en" article-type="research article"><front><journal-meta><journal-id journal-id-type="publisher-id">WJCD</journal-id><journal-title-group><journal-title>World Journal of Cardiovascular Diseases</journal-title></journal-title-group><issn pub-type="epub">2164-5329</issn><publisher><publisher-name>Scientific Research Publishing</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.4236/wjcd.2022.1211053</article-id><article-id pub-id-type="publisher-id">WJCD-121605</article-id><article-categories><subj-group subj-group-type="heading"><subject>Articles</subject></subj-group><subj-group subj-group-type="Discipline-v2"><subject>Medicine&amp;Healthcare</subject></subj-group></article-categories><title-group><article-title>
 
 
  Complications of Peripartum Cardiomyopathy at the Departmental University Hospital Teaching of Borgou (Benin) in 2022: About 3 Cases
 
</article-title></title-group><contrib-group><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Léopold</surname><given-names>Houétondji Codjo</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Serge</surname><given-names>Hugues Mahougnon Dohou</given-names></name><xref ref-type="aff" rid="aff2"><sup>2</sup></xref><xref ref-type="corresp" rid="cor1"><sup>*</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Sèdjro</surname><given-names>Raoul Atade</given-names></name><xref ref-type="aff" rid="aff3"><sup>3</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Fabrice</surname><given-names>Atika</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Hamondji</surname><given-names>Nicolas Amegan</given-names></name><xref ref-type="aff" rid="aff4"><sup>4</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Chabi</surname><given-names>Olaniran Alphonse Biaou</given-names></name><xref ref-type="aff" rid="aff5"><sup>5</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Kayivi</surname><given-names>Murielle Hounkponou</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Djidjoho</surname><given-names>Arnaud Sonou</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Mahouna</surname><given-names>Philippe Adjagba</given-names></name><xref ref-type="aff" rid="aff6"><sup>6</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Marielle</surname><given-names>Dorine Soude</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Dominique</surname><given-names>Sacca</given-names></name><xref ref-type="aff" rid="aff7"><sup>7</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Mèdéssè</surname><given-names>Rolande Quenum</given-names></name><xref ref-type="aff" rid="aff8"><sup>8</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Aude</surname><given-names>Sourou Bodjrenou</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Martin</surname><given-names>Dèdonougbo Houenassi</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib></contrib-group><aff id="aff7"><addr-line>Cardiology Department of Atacora-Donga Department Hospital Center (CHD-A/D), Natitingou, Benin</addr-line></aff><aff id="aff4"><addr-line>Doctoral School of Health Sciences, University of Abomey Calavi, Cotonou, Benin</addr-line></aff><aff id="aff3"><addr-line>Teaching and Research Department of Gynecology and Obstetric (CHUD-B/A), Faculty of Medicine, University of Parakou, 
Parakou, Benin</addr-line></aff><aff id="aff8"><addr-line>Teaching and Research Unit in Cardiology, Faculty of Medicine (CHU-OP), University of Abomey Calavi, Cotonou, Benin</addr-line></aff><aff id="aff6"><addr-line>Cardiology Teaching and 6 Research Unit (CHU-MEL), Faculty of Health Sciences, University of Abomey Calavi, Cotonou, Benin</addr-line></aff><aff id="aff5"><addr-line>Regional Institute of Public Health, University of Abomey Calavi, Cotonou, Benin</addr-line></aff><aff id="aff1"><addr-line>Cardiology Teaching and Research Unit (CNHU-HKM), Faculty of Health Sciences, University of Abomey Calavi, Cotonou, Benin</addr-line></aff><aff id="aff2"><addr-line>Teaching and Research Unit in Cardiology (CHUD-B/A), Faculty of Medicine, University of Parakou, Parakou, Benin</addr-line></aff><pub-date pub-type="epub"><day>03</day><month>11</month><year>2022</year></pub-date><volume>12</volume><issue>11</issue><fpage>514</fpage><lpage>526</lpage><history><date date-type="received"><day>21,</day>	<month>October</month>	<year>2022</year></date><date date-type="rev-recd"><day>27,</day>	<month>November</month>	<year>2022</year>	</date><date date-type="accepted"><day>30,</day>	<month>November</month>	<year>2022</year></date></history><permissions><copyright-statement>&#169; Copyright  2014 by authors and Scientific Research Publishing Inc. </copyright-statement><copyright-year>2014</copyright-year><license><license-p>This work is licensed under the Creative Commons Attribution International License (CC BY). http://creativecommons.org/licenses/by/4.0/</license-p></license></permissions><abstract><p>
 
 
  Introduction:
   Peripartum cardiomyopathy (PPCM) is a dilated cardiomyopathy occurring in the last month of pregnancy or the first five months postpartum without pre-existing cardiovascular pathology. It is a major cause of pregnancy-related heart failure with high morbidity and mortality. In severe forms (10% to 15% 
  of cases), thrombo-embolic complications are the main cause. The initial hemodynamic evolution is totally unpredictable and sometimes extremely brutal and fatal. The objective of this work was to show the often pejorative evolution of PPCM in our country. 
  <b style="white-space:normal;">Methods:</b>
   We report in this work three serious clinical cases revealing the complications of this PPCM among patients admitted 
  to
   the cardiology department of the CHUD-B/A in 2022 for hea
  rt failure. The data were collected according to the Declaration of Helsinki. 
  <b style="white-space:normal;">Patients and Observations:</b>
   The first case was a PPCM with severe 
  left ventricular (LV) systolic dysfunction complicated by spontaneous left intraventricular contrast and right superficial sylvian ischemic stroke. 
  The second case reports a global cardiac decompensation of a PPCM with severe LV systolic 
  dysfunction complicated by an apical thrombus. The third case is that of a state of cardiogenic shock complicating a PPCM with severe LV systolic dysfunction. Among our 03 patients presenting these severe forms of PPCM, the evolution, in spite of the symptomatic and prognostic treatments of the heart failure
  ,
   and even of the complications, was unfavourable with death in two of them. 
  <b style="white-space:normal;">Conclusion</b>
  : Complications of PPCM are frequent and fatal in Benin.
 
</p></abstract><kwd-group><kwd>Cardiomyopathy</kwd><kwd> Peripartum</kwd><kwd> Complications</kwd><kwd> Parakou</kwd><kwd> Benin</kwd></kwd-group></article-meta></front><body><sec id="s1"><title>1. Introduction</title><p>Peripartum cardiomyopathy (PPCM) is defined as dilated cardiomyopathy occurring in the last month of pregnancy or in the first five months postpartum [<xref ref-type="bibr" rid="scirp.121605-ref1">1</xref>] [<xref ref-type="bibr" rid="scirp.121605-ref2">2</xref>]. It is recognized as a major cause of pregnancy-related heart failure with high morbidity and mortality [<xref ref-type="bibr" rid="scirp.121605-ref3">3</xref>]. Indeed, it represents 2.04% of cardiology admissions in Parakou in 2019 [<xref ref-type="bibr" rid="scirp.121605-ref4">4</xref>]. In Cotonou, this frequency was 2.40% in 2016 [<xref ref-type="bibr" rid="scirp.121605-ref5">5</xref>]. These high frequencies of PPCM in Benin are close to that reported by Ngamami in Brazzaville in 2014 (2.7%) [<xref ref-type="bibr" rid="scirp.121605-ref6">6</xref>] and confirm that the risk of PPCM is higher in women of African origin [<xref ref-type="bibr" rid="scirp.121605-ref7">7</xref>]. PPCM is a serious condition with high mortality. In Parakou in 2019, the case fatality at 6 months was 9.5% [<xref ref-type="bibr" rid="scirp.121605-ref4">4</xref>] compared to 11.5% in Zimbabwe in 2017 [<xref ref-type="bibr" rid="scirp.121605-ref8">8</xref>]. In 2014, in a series by Pio et al., mortality was 8.3% [<xref ref-type="bibr" rid="scirp.121605-ref9">9</xref>]. These deaths were most often related to sudden death or the occurrence of complications. These were most often arrhythmias, thromboembolic complications and new decompensations responsible for numerous rehospitalizations. In severe forms (10% - 15% of cases), these complications are revealing of the disease [<xref ref-type="bibr" rid="scirp.121605-ref4">4</xref>] [<xref ref-type="bibr" rid="scirp.121605-ref5">5</xref>]. We report in this article three (03) clinical cases which show the severity of complications of PPCM in our setting.</p></sec><sec id="s2"><title>2. Methods</title><p>These were patients hospitalized for heart failure in a peripartum setting in the cardiology department at the Departmental University Hospital teaching of Borgou (Benin) in the months of May and June 2022. The presentation of these cases was made in accordance with the principles set out in the Helsinki Declaration of 1975 [<xref ref-type="bibr" rid="scirp.121605-ref10">10</xref>]. Thus, the dignity of the patients, the anonymity and the confidentiality of the data were respected. The authorization of the head of the cardiology department and of the hospital management was obtained for the publication of these three clinical cases.</p><p>Patients and observations</p><p>Clinical case N˚ 1 (Figures 1-3):</p><p>This was a 26 year old female patient, gender 2, parity 2 (G2P2) and 5 months old infant, with no known cardiovascular history, referred from the neurology</p><p>department on May 24, 2022 for a stroke assessment. The history revealed a four-week-old onset of exertional dyspnea episodes, stage 3 according to the New York Heart Association (NYHA) classification. One week later, a neurological deficit of sudden onset with right hemiparesis, without loss of consciousness, was associated. The brain scan performed three weeks later concluded to a left superficial sylvian stroke. She was therefore referred to a cardiology consultation for an etiological assessment of the stroke.</p><p>The physical examination revealed a stable hemodynamic state with blood pressure (BP) = 109/74mmHg in the right arm and 109/73mmHg in the left arm, heart rate = 110 bpm; saturation 96% in room air, temperature 36˚C, a left heart failure syndrome (dyspnea at the slightest effort, crackles at the base of both lung fields), a right heart failure syndrome (discrete edema of the pelvic limbs, hepatica with hepato-jugular reflux) and a mitral insufficiency murmur of intensity 2/6. The neurological examination noted a proportional right hemiparesis with a segmental muscle strength of 4/5, hypoesthesia of the right hemisphere.</p><p>The electrocardiogram showed a regular sinus tachycardia at 110 bpm, a delay in septal activation, asymmetric negative T-wave repolarization abnormalities in the apical-lateral region.</p><p>Cardiac echocardiography showed a dilated left ventricle (DTDVG = 64 mm), hypokinetic with severe systolic dysfunction of the left ventricle (LVEF 23% on Simpson biplane). There was spontaneous left ventricular contrast; high left ventricular filling pressures (E/Ea = 15.76; dilated left atrial area = 28 cm<sup>2</sup>), moderate mitral insufficiency due to annular dilatation. The right ventricle is normal. No significant valvular anomaly. The inferior vena cava was dilated to 22 mm uncomplicated. The pericardium was free and the leaflets were normal.</p><p>The results of the biology are noted in <xref ref-type="table" rid="table1">Table 1</xref> below.</p><p>Given the absence of heart disease before pregnancy and the occurrence of symptoms after delivery, the diagnosis of moderate global cardiac decompensation of peripartum cardiomyopathy with severe LV dysfunction complicated by spontaneous left intraventricular contrast and left superficial sylvian ischemic stroke was made. She was put on diuretic treatment (Furosemide injection 40 mg every 6 hours then relay by lasilix tablets 40 mg), bromocriptine 2.5 mg (1/2 tablet D1; 1 tablet D2 then 1 cp x<sup>2</sup>/day from D3); angiotensin-converting enzyme inhibitor (ramipril tablet 5 mg/day); anticoagulation (enoxaparin injection in curative dose); antiplatelet agent (aspirin 75 mg/day), statin (atorvastatin 40 mg/day) and physical therapy. The combination of anticoagulation and antiplatelet agent was introduced after the neurological consultation. This patient</p><table-wrap id="table1" ><label><xref ref-type="table" rid="table1">Table 1</xref></label><caption><title> Results of the biological examinations of clinical case N˚1</title></caption><table><tbody><thead><tr><th align="center" valign="middle" >Bio Chemistry</th><th align="center" valign="middle" >Blood count</th></tr></thead><tr><td align="center" valign="middle" >uremia = 0.31 g/L</td><td align="center" valign="middle" >Hemoglobin = 14 g/dl</td></tr><tr><td align="center" valign="middle" >Creatinine = 7.14 mg/L</td><td align="center" valign="middle" >White blood cell count = 8 G/L</td></tr><tr><td align="center" valign="middle" >Natremia = 135 meq/L; Kalemia = 4.45 meq/L Chloremia = 102.4 meq/L</td><td align="center" valign="middle" >Platelet count = 279 G/L</td></tr></tbody></table></table-wrap><p>was seen in consultation after her exeat and the examination noted a regression of the signs of cardiac failure with a weight loss of five kg and an improvement of the motor deficit; the muscular force having passed from 4/5 to 5/5.</p><p>Clinical case N˚ 2 (Figures 4-6):</p><p>Aged 26 years, primigravida and without known cardiovascular history, this patient consulted on June 02, 2022 for a dyspnea stage 4 according to the NYHA classification associated with a cough with mucous sputum and a bilateral edema of the lower limbs. This dyspnea had been evolving for one (01) month following a caesarean section for severe pre-eclampsia. The patient consulted a center for care without any real improvement of symptoms and was then referred to cardiology for better management.</p><p>The physical examination at admission revealed blood pressure (BP) = 122/78 mmHg in the right arm and 118/71 mmHg in the left arm, heart rate = 91 bpm;</p><table-wrap id="table2" ><label><xref ref-type="table" rid="table2">Table 2</xref></label><caption><title> Results of the biological examinations of clinical case N˚2</title></caption><table><tbody><thead><tr><th align="center" valign="middle" >Bio Chemistry</th><th align="center" valign="middle" >Blood count</th></tr></thead><tr><td align="center" valign="middle" >uremia = 1.32 g/L</td><td align="center" valign="middle" >Hemoglobin = 10.8 g/dl</td></tr><tr><td align="center" valign="middle" >creatinine = 16.76 mg/L</td><td align="center" valign="middle" >White blood cell count = 10.9 G/L,</td></tr><tr><td align="center" valign="middle" >Natremia = 127 meq/L, Kalemia = 3.63 meq/L, Chloremia = 94.5 meq/L</td><td align="center" valign="middle" >Platelet count = 182 G/L</td></tr></tbody></table></table-wrap><p>saturation 99% on room air, temperature 36.7˚C, right heart failure syndrome (pelvic limb edema, hepatorrhea with hepato-jugular reflux) and left heart failure syndrome (resting dyspnea, crackles at the base of both lung fields). The rest of the physical examination was normal.</p><p>The electrocardiogram recorded a regular sinus tachycardia at 110 bpm, anteroseptal R-wave planing and asymmetric negative T-waves in the low inferolateral. A chest X-ray could not be performed due to lack of funds.</p><p><xref ref-type="table" rid="table2">Table 2</xref> summarizes the biological results of the patient with moderate anemia, functional renal failure and hyperleukocytosis.</p><p>Cardiac echocardiography revealed hypokinetic dilated heart disease with severe bi-ventricular systolic dysfunction (LVEF = 10%, subaortic LTI = 6.4 cm with cardiac output lowered to 1.8 L/min, TAPSE = 6.6 mm, S’t = 6.7 cm/s). Presence of an apical thrombus of 23.8 mm &#215; 8 mm. Left ventricular filling pressures were high (E/Ea = 15.51; dilated left atrial area = 24 cm<sup>2</sup>). There was moderate central mitral insufficiency and no aortic valve disease. PAPS was estimated at 30 mmHg on moderate IT flow, Vmax IT = 2.4 m/s. The inferior vena cava was 20 mm uncomplicated. There was a systolic pericardial detachment over both ventricles.</p><p>Given the absence of heart disease before pregnancy and the occurrence of symptoms after delivery, a PPCM was diagnosed. It was a global cardiac decompensation of a PPCM with severe bi-ventricular systolic dysfunction complicated by low cardiac output and an apical thrombus. She benefited from hydrosodic depletion with injectable furosemide 40 mg/hour, injectable dopamine 3 microgram/kg/min, curative anticoagulation with enoxaparin and potassium supplementation (Diffu K one capsule x<sup>3</sup>/day). The initial evolution was marked by a poor diuretic response with persistent congestive signs in a context of hyponatremia at 121 meq/l which required correction. In a second time, the patient presented an alteration of consciousness and then a cardio-respiratory arrest which was not recovered.</p><p>Clinical case N˚ 3 (Figures 7-9):</p><p>This was a 32 year old female patient, G3P3, with no known cardiovascular history admitted for dyspnea. The onset of symptoms was three (03) months after a vaginal delivery, with NYHA stage 2 exertional dyspnea associated with bilateral edema of the lower limbs and pain in the right hypochondrium. This symptomatology persisted in spite of various treatments received in different health structures. Due to the worsening of the dyspnea and the onset of an anasarca state, she was hospitalized in our department.</p><p>The physical examination revealed on admission: a poor general condition, palpebral mucous membranes with little color, arterial hypotension (BP = 84/56mmHg in the right arm and 90/60mmHg in the left arm), tachycardia at 125 bpm; a saturation of 88% in room air, temperature of 36˚C, polypnea at 38 cycles/min, a right heart failure syndrome (anasarca state, hepatorrhea with hepato-jugular reflux) and a left heart failure syndrome (dyspnea at rest, crepitating rales in half of the two pulmonary fields), signs of peripheral hypoperfusion (cold extremities, oliguria)</p><p>The electrocardiogram showed a sinus tachycardia made irregular by isolated ventricular extrasystoles with a mean heart rate of 125 bpm, a diffuse microvoltage and diffuse disorders of repolarization.</p><p>Anemia at 9 g/L and renal failure were noted in the biology results recorded in <xref ref-type="table" rid="table3">Table 3</xref> below.</p><p>Cardiac echocardiography showed dilated, hypokinetic heart disease with severe left ventricular systolic dysfunction, LVEF 22% in simpson biplane, cardiac output 4 L/min under dobutamine infusion. Left ventricular filling pressures were high (restrictive mitral profile E/A = 2.66, left atrium dilated to 26 cm<sup>2</sup>). There was moderate mitral insufficiency due to ring dilatation. The right ventricle was normal. The inferior vena cava was dilated to 24 mm with little complication. In addition, there was a small to moderate pericardial effusion in the right cavities (16 mm in the right atrium and 8 mm in the right ventricle), without</p><table-wrap id="table3" ><label><xref ref-type="table" rid="table3">Table 3</xref></label><caption><title> Results of biological examinations of clinical case N˚3</title></caption><table><tbody><thead><tr><th align="center" valign="middle" >Bio Chemistry</th><th align="center" valign="middle" >Blood count</th></tr></thead><tr><td align="center" valign="middle" >uremia = 0.57 g/L</td><td align="center" valign="middle" >Hemoglobin = Hb = 9 g/dl</td></tr><tr><td align="center" valign="middle" >creatininemia = 17.49 mg/L,</td><td align="center" valign="middle" >White blood cell count = 8.23 G/L,</td></tr><tr><td align="center" valign="middle" >Natremia = 140 meq/L, Kalemia = 4.44 meq/L, Chloremia = 0.8 meq/L,</td><td align="center" valign="middle" >Platelet count = 80 G/L</td></tr></tbody></table></table-wrap><p>hemodynamic consequences.</p><p>The diagnosis of cardiogenic shock complicating a peripartum dilated cardiomyopathy with severe left ventricular dysfunction was made. She was put on dobutamine 5 gamma/kilogram/min; furosemide 250 mg/24h then increased to 500 mg/24h at PES in front of the bad diuretic response, hydrochlorothyazide, preventive anticoagulation, potassium supplementation, blood transfusion.</p><p>The initial evolution was marked by a normalization of the blood pressure under amines, a regression of the signs of peripheral hypoperfusion, and an unsatisfactory diuretic response. In the aftermath, the patient presented an unrecovered cardiorespiratory arrest.</p></sec><sec id="s3"><title>3. Discussion</title><p>The prognosis of PPCM is essentially related to three factors: the severity of the initial hemodynamic failure and its response to therapeutic measures, thromboembolic complications, and recovery of LVEF away from the acute episode [<xref ref-type="bibr" rid="scirp.121605-ref11">11</xref>].</p><p>The mortality rate in the acute phase due to refractory shock, embolic complications, or complications related to resuscitation measures is not well known, but the figure of 10% to 15% is generally accepted [<xref ref-type="bibr" rid="scirp.121605-ref12">12</xref>]. However, this figure is based on relatively old publications, and it is likely that the use of modern therapies for heart failure and the possibility of transient circulatory assistance in the most severe forms have contributed in Western countries to improve the prognosis of the acute phase.</p><p>Thrombo-embolic complications:</p><p>Embolic complications are known to be frequent and remain the most feared, due to their particularly dramatic consequences in case of neurological accident in these young patients [<xref ref-type="bibr" rid="scirp.121605-ref13">13</xref>]. They are related to the hypercoagulable state of pregnancy, cardiac dilatation, alteration of the LVEF, bed rest and sometimes caesarean section. These include stroke, coronary embolism, renal or mesenteric infarction [<xref ref-type="bibr" rid="scirp.121605-ref12">12</xref>] [<xref ref-type="bibr" rid="scirp.121605-ref13">13</xref>].</p><p>In the first clinical case of this work, PPCM was complicated by spontaneous left intraventricular contrast and right superficial sylvian ischemic stroke.</p><p>The second patient presented with global cardiac decompensation of a PPCM with severe LV systolic dysfunction complicated by an apical thrombus. The US registry of patients hospitalized for PPCM found that thromboembolic events were the most common serious complication at 6.6% [<xref ref-type="bibr" rid="scirp.121605-ref14">14</xref>]. Numerous cases of intraventricular thrombus have been reported [<xref ref-type="bibr" rid="scirp.121605-ref14">14</xref>] [<xref ref-type="bibr" rid="scirp.121605-ref15">15</xref>] [<xref ref-type="bibr" rid="scirp.121605-ref16">16</xref>]. In Cotonou, Adjabga et al. in 2016 found 3 cases (7.9%) of thrombo-embolic complications (01 pulmonary embolism) and 2 cases of ischemic stroke on left intraventricular thrombus) [<xref ref-type="bibr" rid="scirp.121605-ref5">5</xref>].</p><p>In Mali in 2021, Tour&#233; et al. published a clinical case reporting an association of PPCM, acute coronary syndrome and stroke [<xref ref-type="bibr" rid="scirp.121605-ref17">17</xref>]. A study conducted in Senegal in 2010 found the presence of left intraventricular thrombus in 30% of patients [<xref ref-type="bibr" rid="scirp.121605-ref18">18</xref>]. This rate is much higher than that found in another study carried out in Mali in 2021 where the proportion of left intraventricular thrombus was 8.54% in patients hospitalized for heart failure [<xref ref-type="bibr" rid="scirp.121605-ref19">19</xref>]. Naibe et al. found three cases of ischemic stroke and two cases of pulmonary embolism in a series of 2214 patients in Chad in 2018 [<xref ref-type="bibr" rid="scirp.121605-ref20">20</xref>]. Ramorasata et al. in Madagascar described in their series a case of intracardiac thrombus with acute ischemia and thrombophlebitis of the lower limbs whose evolution resulted in the death of the patient in a picture of acute respiratory distress, evocative of pulmonary embolism [<xref ref-type="bibr" rid="scirp.121605-ref21">21</xref>]. In Congo in 2014, Mongo-ngamami et al. noted the occurrence of a pulmonary embolism in 5 cases (11.9%) and an ischemic stroke in 1 case [<xref ref-type="bibr" rid="scirp.121605-ref6">6</xref>]. Kane et al. [<xref ref-type="bibr" rid="scirp.121605-ref22">22</xref>] and Ford et al. [<xref ref-type="bibr" rid="scirp.121605-ref23">23</xref>] reported 12% and 10% of stroke cases respectively.</p><p>It should be remembered that in this work, the patients consulted late after the onset of symptoms with an unfavorable evolution. Hence the need for an early consultation for an early diagnosis leading to an adapted treatment. The management of thrombo-embolic complications requires the initiation of curative anticoagulant treatment, which was effective in our patients.</p><p>Hemodynamic complications:</p><p>Regarding hemodynamic complications, the evolution of the disease is totally unpredictable, it can be in 24 - 48 h towards a state of refractory cardiogenic shock requiring extracorporeal circulatory assistance while waiting for functional recovery or heart transplantation [<xref ref-type="bibr" rid="scirp.121605-ref24">24</xref>] [<xref ref-type="bibr" rid="scirp.121605-ref25">25</xref>]. The long-term evolution of PPCM is unpredictable: a restitution ad integrum of the cardiac function is observed in half of the cases, in a third of the cases we note a stabilization of the lesions, only a small number will progressively evolve towards refractory cardiac failure indicating a cardiac transplantation. According to Codjo et al. [<xref ref-type="bibr" rid="scirp.121605-ref4">4</xref>], the evolution during hospitalization was favorable in 86.48% of cases. In post-hospitalization, 78.26% of patients had regression of congestive signs. This rate is significantly higher than the proportion found by Adjagba et al. in 2017 [<xref ref-type="bibr" rid="scirp.121605-ref5">5</xref>]. This difference was explained by the absence of ultrasound confirmation of recovery during follow-up, as a patient may show no congestive signs despite impaired systolic function. Failure to recover full cardiac function within 6 months postpartum is indicative of progression to chronic cardiomyopathy [<xref ref-type="bibr" rid="scirp.121605-ref1">1</xref>] [<xref ref-type="bibr" rid="scirp.121605-ref26">26</xref>]. The risk of recurrence in a subsequent pregnancy is variable according to the studies and can vary from 25% to 100%.</p><p>The third clinical case reported cardiogenic shock occurring on a PPCM. Jihad et al. in 2018 reported a case of acute pulmonary oedema (APO) on PPCM [<xref ref-type="bibr" rid="scirp.121605-ref27">27</xref>]. In their study the evolution was favorable after non-invasive ventilation(NIV) and loop diuretic therapy. Adjabga et al. found four (4) cases (10.5%) of cardiogenic shock [<xref ref-type="bibr" rid="scirp.121605-ref5">5</xref>].</p><p>Acute pulmonary oedema (APO) and cardiogenic shock were cited as haemodynamic complications in 5.7% and 3.4% respectively in the study by Bamba-kamagat&#233; et al. in Abidjan [<xref ref-type="bibr" rid="scirp.121605-ref28">28</xref>]. Pio M et al. in Lom&#233; reported four deaths in a study conducted on 48 patients with PPCM. In fact, these authors noted three cases of sudden death at home and one case of refractory heart failure during hospitalization [<xref ref-type="bibr" rid="scirp.121605-ref9">9</xref>]. Naibe et al. recorded four (20) deaths by cardiogenic shock in a series of 2214 patients [<xref ref-type="bibr" rid="scirp.121605-ref8">8</xref>]. In 2019, Codjo et al. reported five deaths out of 74 patients at 6 months of follow-up for PPCM; an overall mortality of 6.76% [<xref ref-type="bibr" rid="scirp.121605-ref4">4</xref>]. The NIV used in the study by Jihad et al. is not available in the majority of the Departmental Hospitals in Benin, in particular in the CHUD Borgou. Also, the delay in consultation and diagnosis found in all our patients constitutes an element of poor prognosis in the sense that it favors the evolution towards severe forms with a poor prognosis.</p><p>Rhythmic complications:</p><p>The rhythmic complications of PPCM are identical to those found in other dilated heart diseases. These include supraventricular and ventricular rhythm disorders. Naibe et al. reported a case of death due to ventricular tachycardia in Chad [<xref ref-type="bibr" rid="scirp.121605-ref20">20</xref>]. Bamba-kamagat&#233; et al. found in Abidjan 6.8% of rhythm disorders in 88 patients during a follow-up of 8 years [<xref ref-type="bibr" rid="scirp.121605-ref28">28</xref>]. In the present work, we did not find this type of complication in our patients.</p><p>We conclude from this work that the delay in diagnosis and adequate management, the severity of the clinical pictures at the time of diagnosis, and the inadequacy of the therapeutic platform in our context could explain these often pejorative evolutions. Hence, there is the need to sufficiently equip our hospitals and to educate the population to consult early in order to avoid the evolution towards complications.</p></sec><sec id="s4"><title>4. Conclusion</title><p>PPCM remains an intriguing pathological entity often posing a significant challenge to the clinician. Complicated forms such as arterial thromboembolic accident and cardiogenic shock as was the case in our observations are grafted with a gloomy prognosis imposing on the carer an early and adapted therapeutic attitude.</p></sec><sec id="s5"><title>Additional Explanation</title><p>This article has no conflict of interest in its writing. All data were collected from our own funds. We did not receive any grants or funding for this study.</p></sec><sec id="s6"><title>Conflicts of Interest</title><p>The authors declare no conflicts of interest regarding the publication of this paper.</p></sec><sec id="s7"><title>Cite this paper</title><p>Codjo, L.H., Dohou, S.H.M., Atade, S.R., Atika, F., Amegan, H.N., Biaou, C.O.A., Hounkponou, K.M., Sonou, D.A., Adjagba, M.P., Soude, M.D., Sacca, D., Quenum, M.R., Bodjrenou, A.S. and Houenassi, M.D. (2022) Complications of Peripartum Cardiomyopathy at the Departmental University Hospital Teaching of Borgou (Benin) in 2022: About 3 Cases. World Journal of Cardiovascular Diseases, 12, 514-526. https://doi.org/10.4236/wjcd.2022.1211053</p></sec></body><back><ref-list><title>References</title><ref id="scirp.121605-ref1"><label>1</label><mixed-citation publication-type="other" xlink:type="simple">Demakis, J.G. and Rahimtoola, S.H. (1971) Peripartum Cardiomyopathy. Circulation, 44, 964-968. https://doi.org/10.1161/01.CIR.44.5.964</mixed-citation></ref><ref id="scirp.121605-ref2"><label>2</label><mixed-citation publication-type="other" xlink:type="simple">Pearson, G.D., Veille, J.-C., Rahimtoala, S., et al. (2000) Peripartum Cardiomyopathy: National Heart, Lung and Blood Institute and Office of Rare Diseases (National Institutes of Health) Workshop Recommendations and Review. JAMA, 283, 1183-1188.  
https://doi.org/10.1001/jama.283.9.1183</mixed-citation></ref><ref id="scirp.121605-ref3"><label>3</label><mixed-citation publication-type="other" xlink:type="simple">Hilfiker-Kleiner, D., Haghikia, A., Nonhoff, J. and Bauersachs, J. (2015) Peripartum Cardiomyopathy: Current Management and Future Perspectives. European Heart Journal, 36, 1090-1097. https://doi.org/10.1093/eurheartj/ehv009</mixed-citation></ref><ref id="scirp.121605-ref4"><label>4</label><mixed-citation publication-type="other" xlink:type="simple">Codjo, H.L., Dohou, S.H.M., Adjagba, P.M., et al. (2021) Peripartum Cardiomyopathy: Epidemiological, Diagnostic, Therapeutic and Outcome Aspects in a Cardiology Setting at Parakou from 2012 to 2019. Cardiologie Tropicale, 166, 10-18.</mixed-citation></ref><ref id="scirp.121605-ref5"><label>5</label><mixed-citation publication-type="other" xlink:type="simple">Adjagba, P.M., Vlavonou, M., Codjo, L., et al. (2017) Peripartum Cardiomyopathy in the Cardiology Department of CNHU-HKM, Cotonou, Benin. Cardiologie Tropicale, 149.</mixed-citation></ref><ref id="scirp.121605-ref6"><label>6</label><mixed-citation publication-type="other" xlink:type="simple">Mongo ngamami, F.S., Ellenga-mbolla, B.F., Nzaka-sikou, S., Kouala-landa, C., Ikama, S.M., Gombet, T.R., et al. (2014) Peripartum Cardiomyopathy: Epidemiological, Clinical and Prognostic Aspects in the Department of Cardiology and Internal Medicine of the Chu de Brazzaville (Congo). Revue. Cames Sante, 2.</mixed-citation></ref><ref id="scirp.121605-ref7"><label>7</label><mixed-citation publication-type="other" xlink:type="simple">Gentry, M.B., Dias, J.K., Luis, A., et al. (2010) African-American Women Have a Higher Risk for Developing Peripartum Cardiomyopathy. Journal of the American College of Cardiology, 55, 654-659. https://doi.org/10.1016/j.jacc.2009.09.043</mixed-citation></ref><ref id="scirp.121605-ref8"><label>8</label><mixed-citation publication-type="other" xlink:type="simple">Gmabahaya, E.T., Hakim, J., Munyandu, N., Matenga, J. and Kao, D. (2017) Peripartum Cardiomyopathy among Cardiovascular Patients Referred for Echocardiography at Parirenyatwa Teaching Hospital, Harare, Zimbabwe. Cardiovascular Journal of Africa, 28, 8-13. https://doi.org/10.5830/CVJA-2016-043</mixed-citation></ref><ref id="scirp.121605-ref9"><label>9</label><mixed-citation publication-type="other" xlink:type="simple">Pio, M., Afassinou, Y., Atta, B., et al. (2013) Evolution and Prognostic Factors of Peripartum Cardiomyopathies in Lomé. Cardiologie Tropicale, 146.</mixed-citation></ref><ref id="scirp.121605-ref10"><label>10</label><mixed-citation publication-type="other" xlink:type="simple">https://www.wma.net/fr/policies-post/declaration-dhelsinki-de-lamm-principes-ethiques-applicables-a-la-recherche-medicale-impliquant-des-etres-humains</mixed-citation></ref><ref id="scirp.121605-ref11"><label>11</label><mixed-citation publication-type="other" xlink:type="simple">Zehir, R., Karabay, C.Y., Kocabay, G., Kalayci, A., Akgun, T. and Kirma, C. (2014) An Unusual Presentation of Peripartum Cardiomyopathy: Recurrent Transient Ischemic Attacks. Revista Portuguesa de Cardiologia, 33, 561.e1-561.e3.  
https://doi.org/10.1016/j.repc.2014.02.025</mixed-citation></ref><ref id="scirp.121605-ref12"><label>12</label><mixed-citation publication-type="other" xlink:type="simple">Bahloul, M., Ben Ahmed, M.N., Laaroussi, L., et al. (2009) Peripartum Cardiomyopathy: Incidence, Pathophysiology, Clinical Manifestations, Therapeutic Management and Prognosis. Annales Francaises d’Anesthésie et de Réanimation, 28, 44-60.  
https://doi.org/10.1016/j.annfar.2008.11.001</mixed-citation></ref><ref id="scirp.121605-ref13"><label>13</label><mixed-citation publication-type="other" xlink:type="simple">Sliwa, K., Fett, J. and Elkayam, U. (2006) Peripartum Cardiomyopathy. The Lancet, 368, 687-693. https://doi.org/10.1016/S0140-6736(06)69253-2</mixed-citation></ref><ref id="scirp.121605-ref14"><label>14</label><mixed-citation publication-type="other" xlink:type="simple">Kolte, D., Khera, S., Aronow, W.S., et al. (2014) Temporal Trends in Incidence and Outcomes of Peripartum Cardiomyopathy in the United States: A Nationwide Population-Based Study. Journal of the American Heart Association, 3, e001056.  
https://doi.org/10.1161/JAHA.114.001056</mixed-citation></ref><ref id="scirp.121605-ref15"><label>15</label><mixed-citation publication-type="other" xlink:type="simple">Shimamoto, T., Marui, A., Oda, M., et al. (2008) A Case of Peripartum Cardiomyopathy with Recurrent Left Ventricular Apical Thrombus. Circulation Journal, 72, 853-854.  
https://doi.org/10.1253/circj.72.853</mixed-citation></ref><ref id="scirp.121605-ref16"><label>16</label><mixed-citation publication-type="other" xlink:type="simple">Kharwar, R.B., Chandra, S., Dwivedi, S.K. and Saran, R.K. (2014) A Pedunculated Left Ventricular Thrombus in a Women with Peripartum Cardiomyopathy: Evaluation by Three Dimensional Echocardiography. Journal of Cardiovascular Ultrasound, 22, 139-143. https://doi.org/10.4250/jcu.2014.22.3.139</mixed-citation></ref><ref id="scirp.121605-ref17"><label>17</label><mixed-citation publication-type="other" xlink:type="simple">Touré, M., Diakité, M., Dembélé, B., et al. (2021) Association Peripartum Emboligenic Cardiomyopathy, Acute Coronary Syndrome and Stroke: About a Case. Health Sciences and Diseases, 22, 139-141.</mixed-citation></ref><ref id="scirp.121605-ref18"><label>18</label><mixed-citation publication-type="other" xlink:type="simple">Kane, A., Mbaye, M., Ndiaye, M.B., et al. (2010) Evolution and Hromboembolic Complications of the Idiopathic Peripartal Cardiomyopathy at Dakar University Hospital: Forward-Looking Study about 33 Cases. Journal de Gynécologie Obstétrique et Biologie de la Reproduction (Paris), 39, 484-489. (In French)  
https://doi.org/10.1016/j.jgyn.2010.01.008</mixed-citation></ref><ref id="scirp.121605-ref19"><label>19</label><mixed-citation publication-type="other" xlink:type="simple">Sangaré, I., Ba, H., Camara, Y., et al. (2021) Thromboembolic Complications of Cardiac Insufficiency in the Cardiology Department of CHU Gabriel Touré (Bamako). Health Sciences and Diseases, 22, 75-79.</mixed-citation></ref><ref id="scirp.121605-ref20"><label>20</label><mixed-citation publication-type="other" xlink:type="simple">Naibe, D.T., Bamouni, J., Mandi, D.G., et al. (2018) Peripartum Cardiomyopathy: Epidemiological and Evolutionary Aspects at the Hopital Général de référénce National de N’Djamena/Tchad. Black African Medicine, 65, 439-447.</mixed-citation></ref><ref id="scirp.121605-ref21"><label>21</label><mixed-citation publication-type="other" xlink:type="simple">Ramorasata, J.A., Randriamahavonjy, R., Rakototiana, A.F., et al. (2009) Intra-Cardiac Thrombus with Acute Ischemia and Lower Limb Thrombophlebitis in Peripartum Cardiomyopathy. Journal of Anesthesia and Emergency Medicine, 1, 11-13.</mixed-citation></ref><ref id="scirp.121605-ref22"><label>22</label><mixed-citation publication-type="other" xlink:type="simple">Kane, A., Mbaye, M., Ndiaye, M.B., et al. (2010) Evolution and Thromboembolic Complications of Idiopathic Peripartum Cardiomyopathy at the Dakar University Hospital: A Prospective Study about 33 Cases. Journal de Gynécologie Obstétrique et Biologie de la Reproduction, 39, 484-489.  
https://doi.org/10.1016/j.jgyn.2010.01.008</mixed-citation></ref><ref id="scirp.121605-ref23"><label>23</label><mixed-citation publication-type="other" xlink:type="simple">Ford, R.F., Barton, J.R., O’Brien, M.J. and Hollingsworth, W.P. (2000) Demographics, Management, and Outcome of Peripartum Cardiomyopathy in a Community Hospital. International Journal of Gynecology &amp; Obstetrics, 182, 1036-1038.  
https://doi.org/10.1067/mob.2000.105402</mixed-citation></ref><ref id="scirp.121605-ref24"><label>24</label><mixed-citation publication-type="other" xlink:type="simple">Vanzetto, G., Martin, A., Bouvaist, H., Marlière, S., Durand, M. and Chvanon, O. (2012) Peripartum Cardiomyopathy: A Multiple Entity. La Presse Médicale, 41, 613-620.  
https://doi.org/10.1016/j.lpm.2012.03.014</mixed-citation></ref><ref id="scirp.121605-ref25"><label>25</label><mixed-citation publication-type="other" xlink:type="simple">Ben, L.D., Slama, A., Khemakhem, K., et al. (1999) Peripartum Cardiomyopathy: A Clinical Case Series. Annales Francaises d’Anesthésie et de Réanimation, 18, 677-678.  
https://doi.org/10.1016/S0750-7658(99)80156-7</mixed-citation></ref><ref id="scirp.121605-ref26"><label>26</label><mixed-citation publication-type="other" xlink:type="simple">Wang, M. (2019) Peripartum Cardiomyopathy Complicated by Stroke Case of a 19-Year-Old Guinean Woman: A Case Report. American Journal of Cardiology and Cardiovascular Diseases, No. 1, 1-3.</mixed-citation></ref><ref id="scirp.121605-ref27"><label>27</label><mixed-citation publication-type="other" xlink:type="simple">Jihad, D., Zakaria, I., Jaouad, K., Driss, M. and Mohamed, D. (2018) Peripartum Cardiomyopathy. The Pan African Medical Journal, 29, Article No. 7.</mixed-citation></ref><ref id="scirp.121605-ref28"><label>28</label><mixed-citation publication-type="other" xlink:type="simple">Bamba-Kamagaté, D., Traoré-Diaby, F., Koffi, F., et al. (2013) Peripartum Cardio- myopathy: Evolution of Therapeutic Management over 8 Years at the Abidjan Heart Institute. Cardiologie Tropicale.%</mixed-citation></ref></ref-list></back></article>